The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Michael R. Pranzatelli

National Pediatric Myoclonus Center and Neuroimmunology Laboratory

Southern Illinois University School of Medicine

Springfield

Illinois; Department of Neurology

Illinois

[email]@siumed.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • National Pediatric Myoclonus Center and Neuroimmunology Laboratory, Southern Illinois University School of Medicine, Springfield, Illinois; Department of Neurology, Illinois. 2002 - 2011

References

  1. Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus. Pranzatelli, M.R., Tate, E.D., Shenoy, S., Travelstead, A.L. Pediatr. Blood. Cancer (2011) [Pubmed]
  2. Chemokine/cytokine profiling after rituximab: reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS. Pranzatelli, M.R., Tate, E.D., Travelstead, A.L., Verhulst, S.J. Cytokine (2011) [Pubmed]
  3. Pediatric dosing of rituximab revisited: serum concentrations in opsoclonus-myoclonus syndrome. Pranzatelli, M.R., Tate, E.D., Verhulst, S.J., Bertolone, S.J., Bhatla, D., Granger, M., Lebowizc, J., Lockhart, S.K., Wiley, J.M. J. Pediatr. Hematol. Oncol. (2010) [Pubmed]
  4. B cell depletion therapy for new-onset opsoclonus-myoclonus. Pranzatelli, M.R., Tate, E.D., Swan, J.A., Travelstead, A.L., Colliver, J.A., Verhulst, S.J., Crosley, C.J., Graf, W.D., Joseph, S.A., Kelfer, H.M., Raju, G.P. Mov. Disord. (2010) [Pubmed]
  5. Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonus. Pranzatelli, M.R., Tate, E.D., Travelstead, A.L., Colliver, J.A. J. Clin. Immunol. (2010) [Pubmed]
  6. Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil. Pranzatelli, M.R., Tate, E.D., Travelstead, A.L., Baumgardner, C.A., Gowda, N.V., Halthore, S.N., Kerstan, P., Kossak, B.D., Mitchell, W.G., Taub, J.W. J. Child Neurol. (2009) [Pubmed]
  7. Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome. Pranzatelli, M.R., Tate, E.D., Crowley, J.M., Toennies, B., Creer, M. Neuropediatrics (2008) [Pubmed]
  8. Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome. Pranzatelli, M.R., Tate, E.D., Hoefgen, E.R., Swan, J.A., Colliver, J.A. Cytokine (2008) [Pubmed]
  9. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. Pranzatelli, M.R., Tate, E.D., Travelstead, A.L., Barbosa, J., Bergamini, R.A., Civitello, L., Franz, D.N., Greffe, B.S., Hanson, R.D., Hurwitz, C.A., Kalinyak, K.A., Kelfer, H., Khakoo, Y., Mantovani, J.F., Nicholson, S.H., Sanders, J.M., Wegner, S. J. Pediatr. Hematol. Oncol. (2006) [Pubmed]
  10. Sleep disturbance and rage attacks in opsoclonus-myoclonus syndrome: response to trazodone. Pranzatelli, M.R., Tate, E.D., Dukart, W.S., Flint, M.J., Hoffman, M.T., Oksa, A.E. J. Pediatr. (2005) [Pubmed]
  11. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Pranzatelli, M.R., Travelstead, A.L., Tate, E.D., Allison, T.J., Moticka, E.J., Franz, D.N., Nigro, M.A., Parke, J.T., Stumpf, D.A., Verhulst, S.J. Neurology (2004) [Pubmed]
  12. CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Pranzatelli, M.R., Travelstead, A.L., Tate, E.D., Allison, T.J., Verhulst, S.J. Mov. Disord. (2004) [Pubmed]
  13. Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus. Pranzatelli, M.R., Travelstead, A.L., Tate, E.D., Allison, T.J., Lee, N.D., Fisher, J., Jasty, R. J. Pediatr. Hematol. Oncol. (2004) [Pubmed]
  14. Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG. Pranzatelli, M.R., Tate, E.D., Kinsbourne, M., Caviness, V.S., Mishra, B. Mov. Disord. (2002) [Pubmed]
 
WikiGenes - Universities